share_log

Chardan Capital Maintains Buy on Ocugen, Raises Price Target to $4

Benzinga ·  May 8, 2023 04:33

Chardan Capital analyst Daniil Gataulin maintains Ocugen (NASDAQ:OCGN) with a Buy and raises the price target from $3.5 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment